| REGiMMUNE Receives $12 Million In Grants To Develop Transplant And ... - Medical News Today (press release) |
|
|
REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders, today announced that ... |